Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 86Carcinoma, Renal Cell 29Lymphoma 26Kidney Neoplasms 26Leukemia 25Leukemia, Myeloid, Acute 24Lymphoma, Follicular 16Lymphoma, Non-Hodgkin 15Lymphoma, Mantle-Cell 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia, Lymphocytic, Chronic, B-Cell 13Breast Neoplasms 12Neoplasm Metastasis 11Lymphoma, Large B-Cell, Diffuse 10Lymphoma, B-Cell, Marginal Zone 10Skin Neoplasms 9Myelodysplastic Syndromes 9Lymphoma, Large-Cell, Immunoblastic 9Hodgkin Disease 9Burkitt Lymphoma 9Neuroblastoma 8Congenital Abnormalities 8Recurrence 7Ovarian Neoplasms 7Multiple Myeloma 7Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 6Leukemia, Myelomonocytic, Chronic 6Gliosarcoma 6Glioblastoma 6

Interventions

Cyclophosphamide 3Trabectedin 2pembrolizumab 1interferon gamma-1b 1fludarabine 1aldesleukin 1Sirolimus 1Pioglitazone 1Interferon-gamma 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Liposarcoma, Myxoid × aldesleukin × Clear all
NCT03450122 2023-10-16

Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

M.D. Anderson Cancer Center

Phase 1 Completed
15 enrolled
Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡